424 related articles for article (PubMed ID: 7901754)
1. Potentiation of gamma-aminobutyric acid-induced chloride currents by various benzodiazepine site agonists with the alpha 1 gamma 2, beta 2 gamma 2 and alpha 1 beta 2 gamma 2 subtypes of cloned gamma-aminobutyric acid type A receptors.
Im HK; Im WB; Hamilton BJ; Carter DB; Vonvoigtlander PF
Mol Pharmacol; 1993 Oct; 44(4):866-70. PubMed ID: 7901754
[TBL] [Abstract][Full Text] [Related]
2. U-93631 causes rapid decay of gamma-aminobutyric acid-induced chloride currents in recombinant rat gamma-aminobutyric acid type A receptors.
Dillon GH; Im HK; Hamilton BJ; Carter DB; Gammill RB; Judge TM; Im WB
Mol Pharmacol; 1993 Oct; 44(4):860-5. PubMed ID: 8232235
[TBL] [Abstract][Full Text] [Related]
3. Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors.
Wafford KA; Bain CJ; Whiting PJ; Kemp JA
Mol Pharmacol; 1993 Aug; 44(2):437-42. PubMed ID: 8102787
[TBL] [Abstract][Full Text] [Related]
4. Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype.
Burgard EC; Tietz EI; Neelands TR; Macdonald RL
Mol Pharmacol; 1996 Jul; 50(1):119-27. PubMed ID: 8700104
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.
Whittemore ER; Yang W; Drewe JA; Woodward RM
Mol Pharmacol; 1996 Nov; 50(5):1364-75. PubMed ID: 8913369
[TBL] [Abstract][Full Text] [Related]
6. Substituted pyrazinones, a new class of allosteric modulators for gamma-aminobutyric acidA receptors.
Im HK; Im WB; Judge TM; Gammill RB; Hamilton BJ; Carter DB; Pregenzer JF
Mol Pharmacol; 1993 Aug; 44(2):468-72. PubMed ID: 8018215
[TBL] [Abstract][Full Text] [Related]
7. Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties.
Araujo F; Ruano D; Vitorica J
J Pharmacol Exp Ther; 1999 Sep; 290(3):989-97. PubMed ID: 10454469
[TBL] [Abstract][Full Text] [Related]
8. Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.
Puia G; Vicini S; Seeburg PH; Costa E
Mol Pharmacol; 1991 Jun; 39(6):691-6. PubMed ID: 1646944
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the benzodiazepine site of rat alpha 6 beta 2 gamma 2-GABAA receptor by replacement of several divergent amino-terminal regions with the alpha 1 counterparts.
Im WB; Pregenzer JF; Binder JA; Alberts GL; Im HK
Br J Pharmacol; 1997 Feb; 120(4):559-64. PubMed ID: 9051290
[TBL] [Abstract][Full Text] [Related]
10. Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.
Knoflach F; Drescher U; Scheurer L; Malherbe P; Mohler H
J Pharmacol Exp Ther; 1993 Jul; 266(1):385-91. PubMed ID: 8392559
[TBL] [Abstract][Full Text] [Related]
11. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological properties of GABAA receptors containing gamma1 subunits.
Khom S; Baburin I; Timin EN; Hohaus A; Sieghart W; Hering S
Mol Pharmacol; 2006 Feb; 69(2):640-9. PubMed ID: 16272224
[TBL] [Abstract][Full Text] [Related]
13. Point mutations of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid(A) receptor affecting modulation of the channel by ligands of the benzodiazepine binding site.
Buhr A; Baur R; Malherbe P; Sigel E
Mol Pharmacol; 1996 Jun; 49(6):1080-4. PubMed ID: 8649346
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system.
Benavides J; Peny B; Durand A; Arbilla S; Scatton B
J Pharmacol Exp Ther; 1992 Nov; 263(2):884-96. PubMed ID: 1331419
[TBL] [Abstract][Full Text] [Related]
15. Molecular actions of (S)-desmethylzopiclone (SEP-174559), an anxiolytic metabolite of zopiclone.
Fleck MW
J Pharmacol Exp Ther; 2002 Aug; 302(2):612-8. PubMed ID: 12130723
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits.
Lin YF; Angelotti TP; Dudek EM; Browning MD; Macdonald RL
Mol Pharmacol; 1996 Jul; 50(1):185-95. PubMed ID: 8700112
[TBL] [Abstract][Full Text] [Related]
17. Allosteric uncoupling after chronic benzodiazepine exposure of recombinant gamma-aminobutyric acid(A) receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity.
Primus RJ; Yu J; Xu J; Hartnett C; Meyyappan M; Kostas C; Ramabhadran TV; Gallager DW
J Pharmacol Exp Ther; 1996 Mar; 276(3):882-90. PubMed ID: 8786565
[TBL] [Abstract][Full Text] [Related]
18. Relative positioning of diazepam in the benzodiazepine-binding-pocket of GABA receptors.
Tan KR; Baur R; Charon S; Goeldner M; Sigel E
J Neurochem; 2009 Dec; 111(5):1264-73. PubMed ID: 19804380
[TBL] [Abstract][Full Text] [Related]
19. Cloning of cDNAs encoding the human gamma-aminobutyric acid type A receptor alpha 6 subunit and characterization of the pharmacology of alpha 6-containing receptors.
Hadingham KL; Garrett EM; Wafford KA; Bain C; Heavens RP; Sirinathsinghji DJ; Whiting PJ
Mol Pharmacol; 1996 Feb; 49(2):253-9. PubMed ID: 8632757
[TBL] [Abstract][Full Text] [Related]
20. Relationship between benzodiazepine receptor occupancy and potentiation of gamma-aminobutyric acid-stimulated chloride flux in vitro of four ligands of differing intrinsic efficacies.
Facklam M; Schoch P; Haefely WE
J Pharmacol Exp Ther; 1992 Jun; 261(3):1106-12. PubMed ID: 1318370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
